• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
The role of gamma interferon in DNA vaccine-induced tumor immunity targeting simian virus 40 large tumor antigen.γ干扰素在靶向猴病毒 40 大肿瘤抗原的 DNA 疫苗诱导肿瘤免疫中的作用。
Cancer Immunol Immunother. 2013 Feb;62(2):371-82. doi: 10.1007/s00262-012-1338-x. Epub 2012 Aug 25.
2
Tumor immunity against a simian virus 40 oncoprotein requires CD8+ T lymphocytes in the effector immune phase.肿瘤对猿猴病毒 40 癌蛋白的免疫需要效应免疫阶段的 CD8+T 淋巴细胞。
J Virol. 2010 Jan;84(2):883-93. doi: 10.1128/JVI.01512-09. Epub 2009 Nov 4.
3
Simian virus 40 large-T-antigen-specific rejection of mKSA tumor cells in BALB/c mice is critically dependent on both strictly tumor-associated, tumor-specific CD8(+) cytotoxic T lymphocytes and CD4(+) T helper cells.在BALB/c小鼠中,猿猴病毒40大T抗原特异性排斥mKSA肿瘤细胞严重依赖于严格肿瘤相关、肿瘤特异性的CD8(+) 细胞毒性T淋巴细胞和CD4(+) T辅助细胞。
J Virol. 2001 Nov;75(22):10593-602. doi: 10.1128/JVI.75.22.10593-10602.2001.
4
CD4+ T lymphocytes are critical mediators of tumor immunity to simian virus 40 large tumor antigen induced by vaccination with plasmid DNA.CD4+ T 淋巴细胞是通过质粒 DNA 疫苗接种诱导的针对猴病毒 40 大肿瘤抗原的肿瘤免疫的关键介质。
J Virol. 2011 Jul;85(14):7216-24. doi: 10.1128/JVI.00543-11. Epub 2011 May 18.
5
Protective immunity in BALB/c mice against the simian virus 40-induced mKSA tumor resulting from injection of recombinant large T antigen. Requirement of CD8+ T lymphocytes.BALB/c小鼠针对因注射重组大T抗原而产生的猿猴病毒40诱导的mKSA肿瘤的保护性免疫。CD8 + T淋巴细胞的需求。
J Immunol. 1996 May 15;156(10):3919-24.
6
In vitro simian virus 40 large tumor antigen expression correlates with differential immune responses following DNA immunization.体外猿猴病毒40大T抗原表达与DNA免疫后的不同免疫反应相关。
Virology. 2005 Feb 5;332(1):28-37. doi: 10.1016/j.virol.2004.08.041.
7
CD4+ T lymphocytes play a critical role in antibody production and tumor immunity against simian virus 40 large tumor antigen.CD4 + T淋巴细胞在抗体产生以及针对猿猴病毒40大肿瘤抗原的肿瘤免疫中发挥关键作用。
Cancer Res. 2003 Mar 1;63(5):1040-5.
8
Role of the innate immune response and tumor immunity associated with simian virus 40 large tumor antigen.先天免疫反应和与猴病毒 40 大肿瘤抗原相关的肿瘤免疫的作用。
J Virol. 2010 Oct;84(19):10121-30. doi: 10.1128/JVI.01095-10. Epub 2010 Jul 28.
9
Quantitation of CD8(+) T-lymphocyte responses to multiple epitopes from simian virus 40 (SV40) large T antigen in C57BL/6 mice immunized with SV40, SV40 T-antigen-transformed cells, or vaccinia virus recombinants expressing full-length T antigen or epitope minigenes.对用猿猴病毒40(SV40)、SV40 T抗原转化细胞或表达全长T抗原或表位小基因的痘苗病毒重组体免疫的C57BL/6小鼠中CD8(+) T淋巴细胞对猿猴病毒40(SV40)大T抗原多个表位的反应进行定量分析。
J Virol. 2000 Aug;74(15):6922-34. doi: 10.1128/jvi.74.15.6922-6934.2000.
10
Predominance of CD4 Th1 and CD8 Tc1 cells revealed by characterization of the cellular immune response generated by immunization with a DNA vaccine containing a Trypanosoma cruzi gene.通过对含有克氏锥虫基因的DNA疫苗免疫产生的细胞免疫反应进行表征,揭示了CD4 Th1细胞和CD8 Tc1细胞的优势。
Infect Immun. 1999 Aug;67(8):3855-63. doi: 10.1128/IAI.67.8.3855-3863.1999.

本文引用的文献

1
Development of a DNA vaccine targeting Merkel cell polyomavirus.针对 Merkel 细胞多瘤病毒的 DNA 疫苗的研制。
Vaccine. 2012 Feb 8;30(7):1322-9. doi: 10.1016/j.vaccine.2011.12.072. Epub 2011 Dec 29.
2
Safety and efficacy of a xenogeneic DNA vaccine encoding for human tyrosinase as adjunctive treatment for oral malignant melanoma in dogs following surgical excision of the primary tumor.一种编码人酪氨酸酶的异种DNA疫苗作为犬口腔恶性黑色素瘤原发肿瘤手术切除后辅助治疗的安全性和有效性
Am J Vet Res. 2011 Dec;72(12):1631-8. doi: 10.2460/ajvr.72.12.1631.
3
Cancer immunotherapy comes of age.癌症免疫疗法走向成熟。
J Clin Oncol. 2011 Dec 20;29(36):4828-36. doi: 10.1200/JCO.2011.38.0899. Epub 2011 Oct 31.
4
Cancer immunotherapy: sipuleucel-T and beyond.癌症免疫疗法:Sipuleucel-T 及其他
Pharmacotherapy. 2011 Aug;31(8):813-28. doi: 10.1592/phco.31.8.813.
5
Immunotherapy in prostate cancer: emerging strategies against a formidable foe.前列腺癌的免疫疗法:对抗强敌的新兴策略。
Vaccine. 2011 Sep 2;29(38):6485-97. doi: 10.1016/j.vaccine.2011.06.088. Epub 2011 Jul 7.
6
The two faces of interferon-γ in cancer.干扰素-γ 在癌症中的双重作用。
Clin Cancer Res. 2011 Oct 1;17(19):6118-24. doi: 10.1158/1078-0432.CCR-11-0482. Epub 2011 Jun 24.
7
DNA fusion vaccines enter the clinic.DNA 融合疫苗进入临床应用。
Cancer Immunol Immunother. 2011 Aug;60(8):1147-51. doi: 10.1007/s00262-011-1042-2. Epub 2011 Jun 5.
8
CD4+ T lymphocytes are critical mediators of tumor immunity to simian virus 40 large tumor antigen induced by vaccination with plasmid DNA.CD4+ T 淋巴细胞是通过质粒 DNA 疫苗接种诱导的针对猴病毒 40 大肿瘤抗原的肿瘤免疫的关键介质。
J Virol. 2011 Jul;85(14):7216-24. doi: 10.1128/JVI.00543-11. Epub 2011 May 18.
9
Hepatitis B virus infection, its sequelae, and prevention by vaccination.乙型肝炎病毒感染、其后遗症和疫苗预防。
Curr Opin Immunol. 2011 Apr;23(2):237-43. doi: 10.1016/j.coi.2010.12.013. Epub 2011 Jan 21.
10
DNA vaccines: an historical perspective and view to the future.DNA 疫苗:历史透视与未来展望。
Immunol Rev. 2011 Jan;239(1):62-84. doi: 10.1111/j.1600-065X.2010.00980.x.

γ干扰素在靶向猴病毒 40 大肿瘤抗原的 DNA 疫苗诱导肿瘤免疫中的作用。

The role of gamma interferon in DNA vaccine-induced tumor immunity targeting simian virus 40 large tumor antigen.

机构信息

Department of Immunology and Molecular Microbiology, Texas Tech University Health Sciences Center, Lubbock, TX 79430, USA.

出版信息

Cancer Immunol Immunother. 2013 Feb;62(2):371-82. doi: 10.1007/s00262-012-1338-x. Epub 2012 Aug 25.

DOI:10.1007/s00262-012-1338-x
PMID:22926061
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11028630/
Abstract

The central role of CD4+ T lymphocytes in mediating DNA vaccine-induced tumor immunity against the viral oncoprotein simian virus 40 (SV40) large tumor antigen (Tag) has previously been described by our laboratory. In the present study, we extend our previous findings by examining the roles of IFN-γ and Th1-associated effector cells within the context of DNA immunization in a murine model of pulmonary metastasis. Immunization of BALB/c mice with plasmid DNA encoding SV40 Tag (pCMV-Tag) generated IFN-γ-secreting T lymphocytes that produced this cytokine upon in vitro stimulation with mKSA tumor cells. The role of IFN-γ as a mediator of protection against mKSA tumor development was assessed via in vivo IFN-γ neutralization, and these experiments demonstrated a requirement for this cytokine in the induction immune phase. Neutralization of IFN-γ was associated with a reduction in Th1 cytokine-producing CD4+ and CD8+ splenocytes, as assessed by flow cytometry analysis, and provided further evidence for the role of CD4+ T lymphocytes as drivers of the cellular immune response. Depletion of NK cells and CD8+ T lymphocytes demonstrated the expendability of these cell types individually, but showed a requirement for a resident cytotoxic cell population within the immune effector phase. Our findings demonstrate the importance of IFN-γ in the induction of protective immunity stimulated by pCMV-Tag DNA-based vaccine and help to clarify the general mechanisms by which DNA vaccines trigger immunity to tumor cells.

摘要

我们实验室之前已经描述了 CD4+T 淋巴细胞在介导 DNA 疫苗诱导针对病毒癌蛋白猴病毒 40(SV40)大肿瘤抗原(Tag)的肿瘤免疫中的核心作用。在本研究中,我们通过在肺部转移的小鼠模型中检查 IFN-γ 和 Th1 相关效应细胞在 DNA 免疫中的作用,扩展了之前的发现。用编码 SV40 Tag 的质粒 DNA(pCMV-Tag)免疫 BALB/c 小鼠会产生 IFN-γ 分泌性 T 淋巴细胞,这些细胞在体外用 mKSA 肿瘤细胞刺激时会产生这种细胞因子。通过体内中和 IFN-γ 来评估其作为保护免受 mKSA 肿瘤发展的介质的作用,这些实验表明该细胞因子在诱导免疫阶段是必需的。IFN-γ 的中和与 Th1 细胞因子产生的 CD4+和 CD8+脾细胞减少有关,通过流式细胞术分析进行评估,并进一步证明了 CD4+T 淋巴细胞作为细胞免疫反应驱动因素的作用。NK 细胞和 CD8+T 淋巴细胞的耗竭证明了这些细胞类型在单独情况下的可替代性,但在免疫效应阶段需要常驻细胞毒性细胞群体。我们的研究结果表明 IFN-γ 在 pCMV-Tag DNA 疫苗刺激的保护性免疫诱导中的重要性,并有助于阐明 DNA 疫苗引发对肿瘤细胞免疫的一般机制。